ClinicalTrials.Veeva

Menu

Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute

A

Assiut University

Status

Not yet enrolling

Conditions

COVID-19

Treatments

Other: disease

Study type

Observational

Funder types

Other

Identifiers

NCT05465759
COVID-19 in cancer patients

Details and patient eligibility

About

Assessment the frequency of SARS COV-2 infection among malignant patients at south Egypt Cancer institute

Full description

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age Cancer is one of the most common examples of immunocompromised states

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Malignant patients.
  • PCR positive for covid-19

Exclusion criteria

  • PCR negative for covid-19

Trial contacts and locations

0

Loading...

Central trial contact

mahmoud ahmed agamy, post graduate

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems